Cardiac sarcoidosis

References

• Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–2165.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med. 1999;160(2):736–755.
   Web of Science ®Google Scholar
• Gillman A, Steinfort C. Sarcoidosis in Australia. Intern Med J. 2007;37(6):356–359.
   Web of Science ®Google Scholar
• Cheong BYC, Muthupillai R, Nemeth M, et al. The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(1):39–46.
   Web of Science ®Google Scholar
• Zipse MM, Sauer WH. Electrophysiologic manifestations of cardiac sarcoidosis. Curr Opin Pulm Med. 2013;19(5):485–492.
   Web of Science ®Google Scholar
• Sekhri V, Sanal S, DeLorenzo LJ, et al. Cardiac sarcoidosis: a comprehensive review. Arch Med Sci. 2011;4:546–554.
   Google Scholar
• Zipse MM, Sauer WH. Cardiac sarcoidosis. Curr Cardiol Rep. 2014;16(8):1–10.
   Web of Science ®Google Scholar
• Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461–468.
   PubMed Web of Science ®Google Scholar
• Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9–21.
   PubMed Web of Science ®Google Scholar
• Freeman AM, Curran-Everett D, Weinberger HD, et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies. Am J Cardiol. 2013;112(2):280–285.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1304–1323.
   Web of Science ®Google Scholar
• Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):19–27.
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007;50(19):1914–1931.
   PubMed Web of Science ®Google Scholar
• Aggarwal NR, Snipelisky D, Young PM, et al. Advances in imaging for diagnosis and management of cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2015;pii:jev142.
   Web of Science ®Google Scholar
• Yazaki Y, Isobe M, Hiramitsu S, et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy. Am J Cardiol. 1998;82(4):537–540.
   Web of Science ®Google Scholar
• Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63(4):329–336.
   PubMed Web of Science ®Google Scholar
• Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET. J Nucl Med. 2003;44(7):1030–1036.
   PubMed Web of Science ®Google Scholar
• Bulkley BH. The use of 201thallium for myocardial perfusion imaging in sarcoid heart disease. Chest. 1977;72(1):27.
   Web of Science ®Google Scholar
• Kidambi A. CMR Pocket Guide. European Society of Cardiology; 2012:1–80. Leeds, UK.
   Google Scholar
• Chung JH, Little BP, Forssen AV, et al. Proton MRI in the evaluation of pulmonary sarcoidosis: comparison to chest CT. Eur J Radiol. 2013;82(12):2378–2385.
   Web of Science ®Google Scholar
• Smedema J-P, Snoep G, van Kroonenburgh MPG, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol. 2005;45(10):1683–1690.
   PubMed Web of Science ®Google Scholar
• Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969–1977.
   PubMed Web of Science ®Google Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–511.
   PubMed Web of Science ®Google Scholar
• Schulz-Menger J. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart. 2005;92(3):399–400.
   Web of Science ®Google Scholar
• Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest. 2002;122(6):1895–1901.
   PubMed Web of Science ®Google Scholar
• Philips B, Madhavan S, James CA, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol. 2014;7(2):230–236.
   Web of Science ®Google Scholar
• Nadel J, Lancefield T, Voskoboinik A, et al. Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death. Eur Heart J Cardiovasc Imaging. 2015;16(6):634–641.
   PubMed Web of Science ®Google Scholar
• Ishikawa T. Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest. 1984;85(3):445.
   Web of Science ®Google Scholar
• Furushima H, Chinushi M, Sugiura H, et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin Cardiol. 2006;27(4):217–222.
   Web of Science ®Google Scholar
• Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008;51(21):e1–e62.
   PubMed Web of Science ®Google Scholar
• Aizer A, Stern EH, Gomes JA, et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol. 2005;96(2):276–282.
   Web of Science ®Google Scholar